136 related articles for article (PubMed ID: 35298396)
1. The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings.
Regazzo D; Bertazza L; Galletta E; Barollo S; Mondin A; Zovato S; Iacobone M; Zilio E; Scaroni C; Radu CM; di Benedetto G; Mian C; Lefkimmiatis K; Occhi G
Endocr Relat Cancer; 2022 Apr; 29(5):273-284. PubMed ID: 35298396
[TBL] [Abstract][Full Text] [Related]
2. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
[TBL] [Abstract][Full Text] [Related]
3. The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of
Regazzo D; Losa M; Albiger NM; Terreni MR; Vazza G; Ceccato F; Emanuelli E; Denaro L; Scaroni C; Occhi G
Eur J Endocrinol; 2017 May; 176(5):543-553. PubMed ID: 28179449
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
[TBL] [Abstract][Full Text] [Related]
5. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
6. Marked cortisol production by intracrine ACTH in GIP-treated cultured adrenal cells in which the GIP receptor was exogenously introduced.
Fujii H; Tamamori-Adachi M; Uchida K; Susa T; Nakakura T; Hagiwara H; Iizuka M; Okinaga H; Tanaka Y; Okazaki T
PLoS One; 2014; 9(10):e110543. PubMed ID: 25334044
[TBL] [Abstract][Full Text] [Related]
7. Resistin knockout mice exhibit impaired adipocyte glucose-dependent insulinotropic polypeptide receptor (GIPR) expression.
Kim SJ; Nian C; McIntosh CH
Diabetes; 2013 Feb; 62(2):471-7. PubMed ID: 23002036
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.
Weaver RE; Donnelly D; Wabitsch M; Grant PJ; Balmforth AJ
Int J Obes (Lond); 2008 Nov; 32(11):1705-11. PubMed ID: 18779825
[TBL] [Abstract][Full Text] [Related]
9. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice.
Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513
[TBL] [Abstract][Full Text] [Related]
10. GIP-GIPR promotes neurite outgrowth of cortical neurons in Akt dependent manner.
Teng L; Guan T; Guo B; Ma C; Lin G; Wu R; Xu M; Liu M; Liu Y
Biochem Biophys Res Commun; 2021 Jan; 534():121-127. PubMed ID: 33321289
[TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation.
Song DH; Getty-Kaushik L; Tseng E; Simon J; Corkey BE; Wolfe MM
Gastroenterology; 2007 Dec; 133(6):1796-805. PubMed ID: 18054552
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular biology of the GIP receptor.
Greenwell AA; Chahade JJ; Ussher JR
Peptides; 2020 Mar; 125():170228. PubMed ID: 31812593
[TBL] [Abstract][Full Text] [Related]
13. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
[TBL] [Abstract][Full Text] [Related]
14. Human GIP(3-30)NH
Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
[TBL] [Abstract][Full Text] [Related]
15. GIP receptor: Expression in neuroendocrine tumours, internalization, signalling from endosomes and structure-function relationship studies.
Reubi JC; Fourmy D; Cordomi A; Tikhonova IG; Gigoux V
Peptides; 2020 Mar; 125():170229. PubMed ID: 31857104
[TBL] [Abstract][Full Text] [Related]
16. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
[TBL] [Abstract][Full Text] [Related]
17. The role of GIP in α-cells and glucagon secretion.
El K; Campbell JE
Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304
[TBL] [Abstract][Full Text] [Related]
18. Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor.
Yuliantie E; van der Velden WJC; Labroska V; Dai A; Zhao F; Darbalaei S; Deganutti G; Xu T; Zhou Q; Yang D; Rosenkilde MM; Sexton PM; Wang MW; Wootten D
Biochem Pharmacol; 2021 Oct; 192():114715. PubMed ID: 34339714
[TBL] [Abstract][Full Text] [Related]
19. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
[TBL] [Abstract][Full Text] [Related]
20. Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations.
Tikhele SH; Pissurlenkar RR; Srivastava S; Saran A; Coutinho EC
J Pept Sci; 2010 Aug; 16(8):383-91. PubMed ID: 20607844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
